A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
Shanghai Henlius Biotech
Shanghai Henlius Biotech
University of Michigan Rogel Cancer Center
Kaiser Permanente
OHSU Knight Cancer Institute
Second Life Therapeutics
Ohio State University Comprehensive Cancer Center
AccSalus Biosciences, Inc.
OncoHost Ltd.
Hangzhou DAC Biotechnology Co., Ltd.
Maria Sklodowska-Curie National Research Institute of Oncology
Rabin Medical Center
Henan Cancer Hospital
Convalife (Shanghai) Co., Ltd.